Completed

Characteristics of Idiopathic Familial Voice Disorders

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being collected

Data Collection

Who is being recruted

Nervous System Diseases+6

+ Neurologic Manifestations

+ Otorhinolaryngologic Diseases

See all eligibility criteria
How is the trial designed

Observational
Study Start: May 1996
See protocol details

Summary

Principal SponsorNational Institute of Neurological Disorders and Stroke (NINDS)
Last updated: July 2, 2017
Sourced from a government-validated database.Claim as a partner

Study start date: May 22, 1996

Actual date on which the first participant was enrolled.

OBJECTIVE: Our purpose is to examine for evidence of genetic risk factors associated with idiopathic laryngeal motor control disorders. During the conception of the protocol, we were interested in investigating the pattern of inheritance of familial voice disorders, specifically spasmodic dysphonia and tremor. Interestingly, the initial search for families revealed several large families with idiopathic vocal fold paralysis with some family members experiencing symptoms of spasmodic dysphonia. During subsequent years, the research has focused on inherited forms of vocal fold paralysis in an attempt to determine the relationship between the laryngeal motor control disorder and other associated neuropathies, and to determine the existence of a specific genetic abnormality. These idiopathic laryngeal motor control disorders were one manifestation of peripheral neuropathies or may be an isolated disorder with only laryngeal involvement. Subsequently, we have shifted our emphasis back to the identification of genetic risk factors for spasmodic dysphonia. Hypothesis 1) Familial risk factors for spasmodic dysphonia result in a particular phenotype and genotype. Hypothesis 2) Environmental risk factors may differentiate between affected and unaffected members of families with spasmodic dysphonia. Hypothesis 3) Whole genome screening will identify SNPs associated with the occurrence of spasmodic dysphonia. STUDY POPULATION: Families with multiple members affected with spasmodic dysphonia, vocal fold paralysis, and tremor will be ascertained. DESIGN: A pedigree will be developed via a questionnaire and voice history. Affected and unaffected family members will be examined to determine the presence and extent of their laryngeal motor control disorder. Affected family members will also undergo neurological examination and nerve and muscle studies to determine the loci of their pathology. A genotype will be developed for affected and unaffected family members, through DNA testing of blood samples. OUTCOME MEASURES: This is a natural history study characterizing the phenotype and genotype of idiopathic laryngeal motor control disorders.

NCT00001552
Principal SponsorNational Institute of Neurological Disorders and Stroke (NINDS)
Last updated: July 2, 2017
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

270 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Healthy volunteers allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Nervous System DiseasesNeurologic ManifestationsOtorhinolaryngologic DiseasesRespiratory Tract DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsLaryngeal DiseasesVoice DisordersDysphonia

Criteria

INCLUSION CRITERIA: Symptoms present during speech and not apparent at rest, Symptoms less evident during whisper, singing or falsetto. Symptoms become worse with prolonged speaking, practice or anxiety. Reflexive and emotional aspects of voice function are unaffected, such as coughing, laughter or crying. EXCLUSION CRITERIA: Any patient with a history of airway obstruction will be excluded from the study. Structural abnormalities affecting the larynx such as vocal fold nodules, polyps, carcinoma, cysts, contact ulcers, or inflammation (laryngitis). Reduction in vocal fold movement range during non-speech tasks such as whistling which would suggest either paralysis or paresis, joint abnormality or neoplasm. No smokers or tobacco users will be included in the study. Subjects with history of a psychiatric disorder, under the care of a psychiatrist, or on medications for treatment of a psychiatric disorder will be excluded from the study. Examples of psychiatric disorders to be excluded are: somatoform disorders, conversion disorders, currently under treatment for a major depression, or a history of schizophrenia or a bipolar disorder. However, a history of a previous episode of a minor reactive depression would not exclude a person from participation.

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 4 locations

University of Iowa

Iowa City, United StatesOpen University of Iowa in Google Maps

National Institutes of Health Clinical Center, 9000 Rockville Pike

Bethesda, United States

Kennedy-Galton Centre Medical & Community Genetics

Harrow, United Kingdom

Institute of Cancer Research

Sutton, United Kingdom
Completed4 Study Centers